United Kingdom vs United States: Immunization, Hib3
United Kingdom
92.0%
in 2024
United States
92.0%
in 2024
United Kingdom rank
84th
United States rank
84th
Immunization, Hib3 over time
- United Kingdom
- United States
How they compare
United Kingdom currently reports 92.0% against 92.0% in United States, a difference of 0.0%.
The two have swapped places 3 times across 30 shared years of data; in 1995 it was United Kingdom ahead.
United Kingdom ranks 84th and United States ranks 84th of 191 countries.
Across the 4 decades both report, United Kingdom averaged higher in 3 and United States in 1.
Head to head by decade
| Decade | United Kingdom | United States | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 92.8% | 92.4% | 0.4% | United Kingdom |
| 2000s | 91.6% | 92.2% | 0.6% | United States |
| 2010s | 94.4% | 92.4% | 2.0% | United Kingdom |
| 2020s | 92.4% | 91.6% | 0.8% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, United Kingdom or United States?
- United Kingdom, at 92.0% against 92.0% in United States as of 2024.
- What is the difference in immunization, hib3 between United Kingdom and United States?
- 0.0%, with United Kingdom ahead.
- How many years of comparable data are there for United Kingdom and United States?
- 30 years are reported by both, from 1995 to 2024.
- How do United Kingdom and United States rank globally for immunization, hib3?
- United Kingdom ranks 84th and United States ranks 84th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.